Therefore, regardless of the presence of other cancer driver genetic abnormalities, the IDCs with a PIK3CA amplification showed a significantly higher histologic grade when compared to the tumors with a PIK3CA mutation (Fig. 7A, p < 0.05), suggesting that PIK3CA gene amplification may directly contribute to a higher histologic grade in IDC. This evidence concerns the gene PIK3CA and cancer.